Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LIN28A anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement LIN28A dans FACS et BR. Il présente une réactivité envers Humain.
N° du produit ABIN2666352

Aperçu rapide pour LIN28A anticorps (ABIN2666352)

Antigène

Voir toutes LIN28A Anticorps
LIN28A (Lin-28 Homolog A (C. Elegans) (LIN28A))

Reactivité

  • 98
  • 30
  • 28
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 83
  • 18
Souris

Clonalité

  • 77
  • 24
Monoclonal

Conjugué

  • 51
  • 7
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp LIN28A est non-conjugé

Application

  • 66
  • 39
  • 27
  • 22
  • 18
  • 14
  • 13
  • 13
  • 9
  • 9
  • 8
  • 3
  • 3
  • 1
Flow Cytometry (FACS), Blocking Reagent (BR)

Clone

14E6-4E6
  • Purification

    The antibody was purified by affinity chromatography.

    Isotype

    IgG2a, IgG2a kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Upon receipt, store undiluted between 2°C and 8°C.
  • Antigène

    LIN28A (Lin-28 Homolog A (C. Elegans) (LIN28A))

    Autre désignation

    Lin28A

    Sujet

    LIN28A is a highly conserved RNA-binding protein and reprogramming factor that plays important roles in development, self-renewal of stem cells, glucose metabolism and tumorigenesis. Lin28A modulates not only miRNAs, particularly the let-7 family miRNAs, but also the translation of mRNAs that are important for cell growth and metabolism. LIN28A/B has been observed to be overexpressed in a wide range of solid tumors and hematological malignancies, and has emerged as a new therapeutic target candidate for cancer.

    Pathways

    Stem Cell Maintenance
Vous êtes ici:
Chat with us!